Founded in 2001, TaiGen Biotechnology Co., Ltd. (“TaiGen Taiwan” or “TaiGen”) is a research-based and product-driven pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer and diabetes-related complications. TaiGen has a wholly-owned Beijing subsidiary with a proven capacity to conduct clinical trials and related registrations. There are 77 FTEs including 80% R&D staffs in Taipei and Beijing offices.
In 2008, TaiGen Taiwan completed a share swap with TaiGen Biopharmaceuticals Holdings Limited (“TaiGen Cayman” or “TaiGen”), and has become a fully owned subsidiary of TaiGen Cayman. TaiGen Cayman will be the legal entity for TaiGen’s IPO; as of Sept. 2013, there are approx. 674 million shares issued and outstanding, each with par value of US$0.001.
TaiGen has raised a total of US$131 million since its inception; principle shareholders include Taiwan’s National Development Fund, Yuen Foong Yu (YFY) Group, China Development Industrial Bank, Shin Kong Life Insurance, Cathay Life Insurance, China Steel Corporation, Taiwan Sugar Corporation, Yao-Hwa Glass Management Commission, and Taiwan Global BioFund.
TaiGen has built a fully-integrated pharmaceutical company by pursuing a business strategy that capitalizes on the management team’s extensive expertise in drug discovery, development, global regulatory approval processes, and commercialization in China. Senior executives at TaiGen were recruited from both major pharmaceutical/biotech companies in the West as well as from Asian-based multinational companies. This unique expertise allows the company to focus on in-licensing innovative drugs targeting Asian-prevalent diseases to complement its own internal research programs as well as to partner its organic drug development programs. In addition, TaiGen has formed marketing alliances to capture the rapidly-expanding Asian pharmaceutical market.
TaiGen’s current pipeline includes ‘first-in-class’ and ‘best-in-class’ products with worldwide IP rights.
7F, 138 Shin Ming Rd. Neihu Dist.,
Taipei, Taiwan 114 R.O.C.
Tel: 886-2-81777072
886-2-27901861
Fax: 886-2-27963606
service@taigenbiotech.com
TaiGen is on the brink of releasing Taiwan’s first innovative drug. In this interview, the Chairman and CEO of the company discusses the development path the company chose to take,…
The Second Generation National Health Insurance Act came into effect in January of this year, introducing a number of major changes to the Taiwanese healthcare framework. Can you please walk…
The chairman and CEO of Medigen shares his insights on a significant past three years for the company, which included both an IPO and major developments for the company’s innovative…
Your grandfather started Chifu a long time ago: the business was registered in 1961. I imagine that the business today is completely different game from the one that it was…
Many key figures from the pharmaceutical industry have told us that the hospitals in Taiwan are the keystone to the country’s healthcare industry: the hospitals provide a very important service…
As a Taiwanese national and Country Head of Novartis Taiwan, what is your opinion on the current state of the pharmaceutical industry in Taiwan, and what are your hopes for…
Giddi Pharma was founded in 1995. What was the vision behind the creation of the company? What founding principles did you have when you founded Giddi? When I founded this…
2010 is ScinoPharm’s thirteenth year of operations. Thirteen does not seem to be an unlucky number for you as your company is doing particularly well at the moment. Perhaps you…
You founded Orient Europharma in 1982, nearly 30 years ago. As you approach the 30 year mark, how has the company evolved to the way it is today, and how…
What is exciting about the Taiwanese market for Hospira today? Hospira is a US-based company, which used to be part of Abbott Laboratories. A major part of the portfolio for…
I was very surprised to see a company called ‘Standard Chemical and Pharmaceutical’ ranked amongst the top three local players in Taiwan: it seems as though your company is far…
Cheng-Ho Tsai, Mackay Memorial Hospital has a unique background and origins. How has this endured through the different stages of the pharmaceutical sector in Taiwan, and how do you see…
Academia Sinica celebrated its 80th anniversary in 2008. After this milestone, how does the institute define its activities today? Academia Sinica was founded more than eighty years ago, as the…
See our Cookie Privacy Policy Here
